hBMP_2基因转染牙龈成纤维细胞对牙周组织再生影响的实验研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
牙周治疗的最终目标是实现牙周组织完全功能性再生,其中包括牙槽骨、牙骨质和牙周膜协调一致地、生理性再生。传统的牙周治疗和引导性组织再生技术虽取得一定的临床效果,但总的看来,尚不能达到牙周组织完全再生的目的。组织工程技术引入牙周病治疗的研究领域,为这一目标的实现带来了新的希望。组织工程学研究的主要内容包括种子细胞的来源、生物载体支架的选择以及细胞/载体支架复合体的构建等三个方面。种子细胞的研究是牙周组织工程的重要内容。牙周膜(PDL)细胞是一组具有多向分化潜能的异质性细胞,其中的未分化间充质细胞可分化为成纤维细胞、成骨细胞或成牙骨质细胞,是牙周组织再生的主要细胞。作为种子细胞,PDL细胞具有一定的局限性,它来源有限,须拔除一定量自体牙才能获得,难以在临床上广泛开展。牙龈成纤维细胞作为牙周组织的组成成分,来源丰富、容易获得、具有很强的生长和自我繁殖能力,在适当的刺激下,可表达成骨细胞表型。人骨形成蛋白2(hBMP_2)是BMP家族中诱骨活性最强的一种,也是唯一能单独诱导成骨的因子,在牙周组织再生和修复中具有重要的作用。本研究利用基因转染技术,将hBMP_2基因转染牙龈成纤维细胞,赋予其成骨细胞特性,探讨其在牙周组织再生中的作用,为将其作为理想的种子细胞应用于牙周组织工程提供实验依据。为此,本研究进行了如下几方面的实验:
     ①将含有pBK-hBMP_2噬菌粒表达载体的大肠杆菌扩增后,以碱裂解法提取pBK—hBMP_2,并进行提纯和酶切鉴定。为以下实验做好准备。
     ②利用脂质体将hBMP_2基因转染至人牙龈成纤维细胞中,经G418筛选后获得了稳定表达hBMP_2基因的细胞克隆;在体外培养扩增后,通过原位杂交、免疫组化、夹心ELISA以及转染细胞培养上清液对MC3T3一E1细胞碱性磷酸
    
     第四军医大学博士学位论文2003-05
    酶活性和骨钙素合成的影响等检测,从mRNA及蛋白水平证实了稳定转染
    hBMP。基因的人牙龈成纤维细胞能够表达具有一定生物学活性的hBMP。。转染
    细胞可持续表达有活性的 hBMP。蛋白达 10代以上。
     ③在上述实验的基础上,对稳定表达hBMP。的人牙龈成纤维细胞从形态、
    增殖特性和细胞周期、碱性磷酸酶活性和骨钙素合成以及体外形成矿化结节
    的能力等方面,对其生物学特性进行了观察。结果显示,部分转染细胞由梭
    形转化为多角形:细胞倍增时间和细胞增殖周期无明显改变;与未转染细胞
    相比,转染细胞碱性磷酸酶活性和骨钙素合成水平明显升高u的.01h 组
    织化学染色表明转染细胞内碱性磷酸酶含量明显升高,并在矿化液作用下形
    成矿化结节。结果提示:hBMPz基因转染后人牙龈成纤维细胞生物学特性发
    生明显改变,表达成骨细胞表型,具有了某些成骨细胞的特点。
     ④将 hBMP。基因转染的人牙龈成纤维细胞与藻酸钙凝胶复合后,进行体
    外培养。利用HE染色技术、免疫组化方法和扫描电镜观察细胞在藻酸钙凝
    胶中的生物学行为。结果显示,转染细胞在凝胶中呈“悬浮”生长,细胞伸
    展良好,并分泌细胞外基质,表达hBMP。。表明藻酸钙凝胶与基因转染的牙
    龈成纤维细胞具有较好的相容性。
     ⑤将hBMPz基因转染后的自体牙龈成纤维细胞作为种子细胞,与藻酸钙
    凝胶复合,植入狗的人工牙周组织缺损区。通过组织学观察和组织学测量,
    评价基因转染牙龈成纤维细胞对牙周组织再生的影响,并以未转染的自体牙
    龈成纤维细胞和PDL细胞作对照。结果发现:SW后,基因转染的牙龈成纤维
    细胞组可见近乎完全的牙周组织再生,未见结合上皮长入、根吸收和骨粘连
    等不良愈合方式。未转染牙龈成纤维细胞组有少数牙位出现骨粘连和根吸
    收;基因转染细胞组新生牙槽骨、牙骨质以及牙周结缔组织附着量与PDL细
    胞组无明显差异(P>0.05),而比未转染牙龈成纤维细胞组有明显多的牙周
    组织再生(P<0.01)。此结果提示,牙龈成纤维细胞经hBMP。基因转染后可替
     一4-
    
     第四军医大学博士学位论文2003.05
    代PDL细胞作为牙周组织工程的种子细胞。
     综上所述,本研究利用PBK—hBMP。表达载体成功地将hBMP。基因转入牙
    龈成纤维细胞,并使其在细胞内稳定表达;基因转染后,牙龈成纤维细胞可
    表达成骨细胞表型;此细胞在藻酸钙凝胶中生长良好,其生物学特性不受影
    响;以藻酸钙凝胶为载体,将基因转染的牙龈成纤维细胞应用于牙周组织工
    程,可很好地促进实验动物根分叉区人工牙周组织缺损的修复。
     本实验结论:外源性的hBMP。基因能够在牙龈成纤维细胞中稳定表达并
    促进其向成骨细胞转化;基因转染的牙龈成纤维细胞与藻酸钙凝胶具有良好
    的相容性;二者复合可很好地促进牙周组织再生。因此,可以初步认为hBMP。
    基因转染牙龈成纤维细胞能作为牙周组织工程的种子细胞。
Periodontal regeneration is expected to reconstitute the injured tissues of the periodontal attachment apparatus physiologically and functionally, including cementum, periodontal ligament and alveolar bone. Traditional periodontal therapy and guided tissue regeneration failed to fullfil the goal. Tissue engineering has been introduced into the field of periodontology, which contribute a new vista to periodontal regeneration. But there are some difficulties in finding proper seeded cells. Owing to its heterogeneity, periodontal ligament (PDL) cell is reagrded as the main source of cell to regenerate periodontal tissues and expected to be the seeded cells in previous studies,, because of their potential of differentiation to fibroblasts, osteoblasts, or cementoblasts. However, there are also some disadvantages for PDL cell to be seeded cells, for example , extraction must be carried out to obtain PDL cell, which is often refused by patients in clinic.
    Gingival fibroblast is also the constituent of periodontal tissues, and easier to obtain clinically than PDL cell, gingival fibroblast have strong proliferation potential and even show some characters of osteoblasts when they are induced by some bone-inducing factors such as human bone morphogenetic protein-2
    
    
    
    (hBMP2) . hBMP2 is a kind of strong bone-inducing factor and plays a crucial role in periodontal regeneration. So, combining GINGIVAL FIBROBLAST with hBMP2 may be used in periodontal tissue engineering to fulfill the periodontal therapy goal.
    This study tries to reform gingival fibroblast to be the seeded cells in periodontal tissue engineering by transfecting hBMP2 gene into gingival fibroblast. Several experiments as below are carried on in this dissertation:
    1. The phagemid expression vector for hBMP2was amplified in E. coli., then, the plasmid was extracted, purified, and identified. All of these were the preparation for following experiments.
    2. hBMP2 gene was transfected into gingival fibroblast by using LipofectAMINE. Positive clones were selected with G-418. The expression of hBMP2 protein in gingival fibroblast transfected were determined by in situ hybridization, immunohistochemistry and sandwich-in ELISA. We also proved the hBMP2 protein has biological activity by investigating ALP activity and osteocalcin (OC) quantity in MC3T3-E1 cells treated with the conditioned media from the gene-transfected gingival fibroblast cultures. The results showed that hBMP2 protein was successfully expressed in gingival fibroblast transfected with hBMP2 gene.
    3 Observed the biological behaviours of gingival fibroblast transfected with hBMP2 gene stably, it was found that the shape of parts of gingival fibroblast changed from fusiform to polygonal; compared with parental cells, there were no obvious difference in doubling time and proliferative ability ; but enhanced both ALP activity and OC quantity of the hBMP2 gene transfected cells (P < 0.01); the ALP synthesis was upregulated in the hBMP2 gene transfected cells by
    
    
    
    histochemistry staining, furthermore, mineral nodules developed in mineralization culture medium after gene transfection. Our results showed that the hBMP2 gene transfected cells expressed osteoblastic phenotype.
    4 We investigated the biological behaviors of hBMP2-transfected gingival fibroblast cultured in calcium alginate gel. The results showed that the cells spread very well in calcium alginate gel, secreted extracellular matrix, and expressed hBMP2 protein.
    5 To evaluate their effects in periodontal tissue regeneration, we compounded the hBMP2-transfected gingival fibroblast to calcium alginate gel and implanted them to artificial furcation defects of dogs. The periodontal apparatus attachments regenerated within 8 weeks. Root resorption and ankylosis were not found in experiment group. In experimental group, the quantities of new formed bone, cementum and connective tissue were more significantly than them in negative control group which implanted gingival fibroblast (P<0.01), but had no obvious differen
引文
1. Wozney JM. Overview of bone morphogenetic proteins [J]. Spine 2002 Aug 15;27(16 Suppl 1):S2-8
    2. Riley EH, Lane JM, Urist MR, et al. Bone morphogenetic protein- 2: biology and application [J]. Clin Orthop, 1996Mar, 324:39-46
    3. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulation of bone formation: molecular clone and activities [J]. Science, 1988;242:1528
    4. Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors [J]. Proc Natl Acad USA, 1988;85:9484
    5. Ishida N, Tsujimoto M, Kanaya T, et al. Expression and characterization of bone morphogenetic protein-2 in silkworm larvae infected with recombinant Bombyx mori nuclear polyhedrosis virus [J]. J Biochem. 1994;115:279
    6. Yim K, Abrams J, Hsu A. Capillary zone electrophoretic resolution of recombinant human bonemorphogenetic protein 2 glycoforms. An investigation into the separation mechanisms for an exquisite separation [J]. J Chromatogr A. 1995 Nov 17;716(1-2):401-12
    7. Tabas JA, Zasloff M, Wasmuth JJ, et al. Bone morphogenetic protein:Chromo-somal localiation of human genes for BMP-1, BMP-2A and BMP-3 [J].Genomics, 1991;9:283
    8. Rao VV, Loffler C, Wozney JM, et al. The gene for bone morphogenetic protein 2A (BMP2A)is localized to human chromosome 20P12 by radioactve and nonradioactive in situ hybridization [J] . Hum Genet. 1992;90:299
    9. Mehler MF, Mabie PC, Zhang D, et al. Bone morphogenetic proteins in the nervous system [J]. Trends Neurosci, 1997,20(7):309-317
    10. Schildauer TA, Bostrom MPG, Lane JM, et al. Embryonic distribution of bone morphogenetic protein 2/4. A new neuronal role in development [J]. Orthop Tans, 1994;426
    11.吕红兵,金岩,张进等.BMP2,4在BALB/c系小鼠颅面部发育中定位表达 第四军医大学学报[J].2001,22(7):670-671
    12.吕红兵 颅神经嵴细胞的培养特性及向神经细胞、成骨细胞的定向诱导分化.西安第四军医大学博士研究生论文,2002
    13. An J, Rosen V, Cox K, et al. Recombinant human bone morphogenetic protein-2 induces a hematopoietic microenvironment in the rat that supports the growth of stem cells [J]. Exp Hematol 1996 Jun;24(7):768-75
    14. Maguer-Satta V, Bartholin L, Jeanpierre S, et al. Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFbeta family [J]. Exp Cell Res 2003 Jan 15; 282 (2):110-20
    
    
    15. Sparrow DB, Kotecha S, Towers N, et al. Xenopus eHAND: a marker for the developing cardiovascular system of the embryo that is regulated by BMPs [J] Mech Dev, 1998;71(1-2):151-163
    16. Schultheiss TM, Burch JB, Lassar AB. A role for bone morphorgenetic proteins in the induction of cardiac myogenesis [J]. Genes Dev, 1997; 11(4): 451~462
    17.谭祖健,李起鸿.BMP及其诱导成骨的分子生物学基础[J].中华骨科杂志.1996;16;9
    18.司晓辉,杨连甲,金岩.BMP2mRNA在骨折愈合过程中的表达及意义[J].第四军医大学学报.1996;17(5):337
    19. Bostrop MP, Lane JM, Berbarian WS, et al. Immunolocalization and expression of bone morphogenetic protein 2 and 4 in fracture healing [J].J Orthop Res. 1995;13(3):357
    20. Nakase T. Nomura S, Yoshikawa H, et al. Transient and localized expression of bone morphogenetic protein messenger RNA during fracture healing[J]. J Bone Miner Res [J]. 1994;9:651
    21. Noden D.M. Factors and mechanisms influencing bone growth. New York: Alan. R.liss. 1982; 167
    22. Gori F, Thomas T, Hicok KC et al. Differentiation of human marrow stromal precursor cells: bone morphogeneticprotein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibitslate adipocyte maturation [J]. J Bone Miner Res 1999 Sep;14(9):1522-35
    23. Gabbitas B, Canalis E. Bone morphogenetic protein-2 inhabits the synthesis of insulinlike growth factor binding protein-5 in bone cell cultures [J] .Endocrinology. 1995;136(6):2397
    24. George HR, Dean TY, Kenji I, et al. Transforming growth factor-β, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cell [J].J cell Physiol. 1996;168:433
    25. Katagiri T, Yamaguchi A, Ikeda T, et al. The non-osteogenic mouse pluripotent cell line, C3H1OT1/2, is induced to differentiate into osteoblastic ceils by recombinant human bone morphogeneticprotein-2 [J]. Biochem Biophys Res Commun. 1990 Oct 15;172(1):295-9.
    26.司晓辉,杨连甲,金岩 转染人骨形成蛋白2基因对NIH3T3细胞生物学行为的影响中华口腔医学杂志 1999,34(2):103—105
    27. Ikeda S, Hachisu R, Yamaguchi A, et al. Radiation retards muscle differentiation but does not affect osteoblastic differentiation induced by bone morphogenetic protein-2 in C2C12 myoblasts [J].Int J Radiat Biol
    
    2000;76(3):403-11
    28. Yamaguchi A, Katagiri T, Ikeda T, et al. Reconunbinant human bone morphogenetic protein-2 stimulates osteoplastic maturation and inhibits myogenic differentatiation in vitro [J] .J Cell Biology, 1991;113(3):681
    29. Yokouchi Y, Sakiyama J. Kameda T, et al. BMP-2/4 mediate programmed cell death in chicken limb buds [J] .Development. 1996;122(12):3725
    30. Zou H, Niswander L. Requirement for BMP signaling in interdigital apoptosis and scale formation [J] . Science. 1996;272:738
    31. Kawamura C, Kizaki M, Ikeda Y. Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells[J]. Leuk Lymphoma 2002 Mar;43(3):635-9.
    32. Ide H, Yoshida, Matsumoto N, et al. Growth regulation of human prostage cancer cells by bone morphogenetic protein-2 [J] .Cancer Res. 1997;57(22):5022~5027
    33. Yamada, Kato, et al.. Bone morphogenetic protein type I B receptor is progressively expressed in malignant glioma tumors [J]. Br J Cancer. 1996;73:624~629
    34. Soda H, Raymond E, Sharma S, et al. Antiproliferitive effects of recombinant human bone morphogenetic protein-2 on human tuman colony-forming units [J]. Anticancer Drugs [J]. 1998; 9(4):327~331
    35.吴景文,章翔,费舟等 人骨形成蛋白-2对人脑胶质瘤细胞周期和增殖的影响[J].第四军医大学学报 2000 21(9):1068-1091
    36.司晓辉,杨连甲,金岩转染骨形成蛋白2基因对细胞凋亡影响的实验研究[J].牙体牙髓牙周病学杂志 1999;9(1):63-5
    37. Zhao GQ, Hogan BL. Evidence that mouse BMP8a and 8b are duplicates gene that plays a role in supermatogenesis and placental development [J]. Mechanisms of Development 1996; 57(2):159
    38. Bostrom K, Watson KE, Hasimoto J, et aJ. Bone morphogenetic protein expression in human atherosclerotic lesions [J].J Clin Invest. 1993;91:1800
    39.岳文 骨形成蛋白基因在口腔肿瘤病理中调控的实验研究第四军医大学博士论文 1999 西安
    40. Guo W, Gorlick R, Ladanyi M, et al.Expression of bone morphogenetic proteins and receptors in sarcomas [J]..Clin Orthop. 1999 Aug; (365): 175-83.
    41. Yoshikawa H, Takaoka K, Hamada H, et al. Clinical significance of bone morphogenetic activity in osteosarcoma. A study of 20 cases [J]. Cancer. 1985 Oct 1;56(7):1682-7.
    42. Kim IY, Lee DH, Ahn HJ, et al. Expression of BMP receptors type-IA, -IB
    
    and-Ⅱ correlates with tumor grade in human prostate cancer tissues [J]. Cancer Res 2000 1;60(11):2840-4
    43. Rose nzweig BL, Imamura T, Okadome T et al. Cloning and characterization o ahuman type Ⅱ receptor for bone morphogenetic proteins [J]. J Proc Natl Acad Sci USA, 1995, 92 (17):7632
    44. Liu F, Hata A, Baker JC, et al. A human Mad protein acting as a BMP-2 regulated transcriptional activator [J] Nature. 1996 Jun 13;381(6583):620-3.
    45. Namiki M, Akiyama S, Katagiri T, et al. A kinase domain-truncated type Ⅰ receptor blocks bone orphogenetic protein-2-induced signal transduction in C2C12 myoblasts [J]. J Biol Chem. 1997, 29; 272 (35):22046-52.
    46. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfal results in a complete lack of bone formation owingto maturational arrest of osteoblasts [J] .Cell. 1997 May 30;89(5):755-64
    47. Graff JM, Bansal A, Melton DA. Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily [J]. Cell. 1996 May 17;85(4):479-87.
    48. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfal: a transcriptional activator of osteoblast differentiation [J].Cell. 1997 30;89(5):747-54
    49. Ohta S, Hiraki Y, Shigeno C, et al. Bone morphogenetic proteins (BMP-2 and BMP-3) induce the late phase expression of the proto-oncogene c-fos in murine osteoblastic MC3T3-E1 cells [J]. FEBS Lett. 1992;314:356
    50. Ghosh Choundhury G, Kim YS, Simon M, et al. BMP2 inhibits platelet-derived growth factor-induced c-fos gene transcription and DNA synthesis in mesangial cells [J]. Involvement of MAP kinase. J Biol Chem 1999;274(16):10897-902
    51. Lee YS, Chuong CM. Activity of protein kinase A is a pivotal step involved in both BMP-2 and cyclic AMP induced chondrogenesis [J]. J Cell Physiol. 1997;170(2):153
    52. Zehentner BK, Dony C, Burtscher H.The transcription factor Sox9 is involved in BMP-2 signaling. J Bone Miner Res 1999;14(10):1734-41
    53.吴勇,吴织芬,王勤涛等 骨形成蛋白-2和成纤维细胞生长因子对人牙周膜细胞增殖的联合效应[J].牙体牙髓牙周病学杂志 2001,11(1):14—16
    54.刘宏,吴织芬,王勤涛等 胰岛素样生长因子—Ⅰ和骨形态发生蛋白-2 对人牙周膜细胞增殖的作用[J].牙体牙髓牙周病学杂志 1999,9(1):31—33
    55.鲁红 吴织芬 应用组织工程方法促进牙周组织再生的实验研究第四军医大学学位论文2002年4月
    56.司晓辉,刘正 骨形成蛋白2基因转染的人牙周膜成纤维细胞的生物学特性[J]
    
    上海第二医科大学学报 2001,21(1):24—27
    57. Fromigue O, Marie PJ, Lomri A. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromai cell proliferation and differentiation [J]. J Cell Biochem 68 (1998), pp. 411-426.
    58.司晓辉,刘正 重组人骨形成蛋白2对人牙周膜成纤维细胞的生物学作用[J],华西口腔医学杂志 2002,20(1):10—13
    59. Zaman KU, Sugaya T, Karo H. Effect of recombinant human platelet-derived growth factor-BB and bone morphogenetic protein-2 application to demineratized dentin on early periodontalligament cell response [J]. J Periodontal Res 1999 Jul:34(5):244-50
    60. Kobayashi M, Takiguchi T, Suzuki R, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic differentiation in cells isolated from human periodontal ligament [J]. J Dent Res 1999 Oct;78(10):1624-33
    61.吴勇,吴织芬,王勤涛等 骨形成蛋白-2和碱性成纤维细胞生长因子对人牙周膜细胞碱性磷酸酶活性的联合效应[J].牙体牙髓牙周病学杂志 2001,11(4):228—230
    62.刘宏,吴织芬,王勤涛等 胰岛素样生长因子-Ⅰ和骨形态发生蛋白-2对人牙周膜细胞增殖的作用[J].中华口腔学杂志 2000,35(5):330—332
    63. Ivanovski S, Li H, Haase HR, er al. Expression of bone associated macromolecules by gingival and periodontal ligament fibroblasts [J]. J Periodontal Res 2001;36(3):131-41
    64. Strayhorn CL, Garrett JS, Dunn RL, et al. Growth factors regulate expression of osteoblast-associated genes [J]. J Periodontol. 1999 Nov;70(11):1345-54.
    65. Saito Y, Yoshizawa T, Takizawa F, et al. A cell line with characteristics of the periodontal ligament fibroblasts isnegatively regulated for mineralization and Runx2/Cbfa1/Osf2 activity, part ofwhich can be overcome by bone morphogenetic protein-2[J]. J Cell Sci 2002 Nov 1:115(Pt 21):4191-200
    66. Pitaru S, Pritzki A, Bar-Kana I, et al. Bone morphogenetic protein 2 induces the expression of cementum attachment protein in human periodontal ligament clones [J]. Connect Tissue Res. 2002:43(2-3):257-64
    67. Liu HW, Yacobi R, Savion N, et al. A collagenous cementum-derived attachment protein is a marker for progenitors of the mineralized tissue-forming cell lineage of the periodontal ligament [J].J Bone Miner Res. 1997 Oct;12(10):1691-9
    
    
    68. Zhao M, Berry JE, Somerman MJ. Bone morphogenetic protein-2 inhibits differentiation and mineralization of cementoblasts in vitro [J]. J Dent Res 2003 Jan;82(1):23-76 3-108.
    69. Kobayashi M, Takiguchi T, Suzuki R, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic differentiation in cells isolated from human periodontal ligament [J]. J Dent Res 1999 Oct;78(10):1624-33
    70. Takiguchi T, Kobayashi M, Nagashima C, et al. Effect of prostaglandin E2 on recombinant human bone morphogenetic protein-2-stimulated osteoblastic differentiation in human periodontal ligament cells [J]. J Periodontal Res 1999 Oct;34(7):431-6
    71. Murphy MG, Mailhot J, Borke J, et al. The effects of rhBMP-2 on human osteosarcoma cells and human gingival fibroblasts in vitro [J]. J Oral Implantol 2001;27(1):16-24
    72. Zhao M, Xiao G, Berry JE, et al. Bone morphogenetic protein2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype [J].. J Bone Miner Res 2002 Aug;17(8):1441-51
    73.邓廉夫,汤雪明,柴本甫等 肿瘤坏死因子-α和骨形成蛋白2诱导成纤维细胞成骨表型表达的体外研究[J].中国修复重建外科杂志 1998,12(4):236
    74.栗向东,胡蕴玉pcDNA3-hBMP2转染对成纤维细胞生物学性状的影响[J].中华外科学杂志 2001,39(4):320
    75.司晓辉,刘正 骨形成蛋白2基因转染人牙周膜成纤维细胞超微结构观察[J]。中华口腔医学杂志 2001,36(4):266
    76. Hasegawa N, Kawaguchi H, Ogawa T, et al. Immunohistochemical characteristics of epithelial cell rests of Malassez during cementum repair [J] J Periodontal Res 2003 Feb;38(1):51-6
    77. Selvig KA, Sorensen RG, Wozney JM, et al. Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration [J]. Periodontol 2002 Sep;73(9):1020-9
    78. Blumenthal NM, Koh-Kunst G, Alves ME, et al. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon [J]. J Periodontol 2002 Dec; 73 (12): 1494-506
    79. Kinoshita A, Oda S, Takahashi K, et al. Periodontal regeneration by application of recombinant human bone morphogeneticprotein-2 to horizontal circumferential defects created by experimental periodontitis in beagle dogs [J]. J Periodontol 1997;68(2):103-9
    
    
    80. King GN, Hughes FJ. Bone morphogenetic protein-2 stimulates cell recruitment and cementogenesis during early wound healing [J].J Clin Periodontol 2001 May;28(5):465-75
    81. Danesh-Meyer MJ. Tissue engineering in periodontics using rhBMP-2 [J].J N Z Soc Periodontol 2000;(85):10-4
    82. Sigurdsson TJ, Tatakis DN, Lee MB, et al. Periodontal regenerative potential of space-providing expandedpolytetrafluoroethylene membranes and recombinant human bone morphogenetic proteins[J]. J Periodontol 1995 Jun;66(6):511-21
    83. King GN, Hughes FJ. Effects of occlusal loading on ankylosis, bone, and cementum formation during bone morphogenetic protein-2 -stimulated periodontal regeneration in vivo [J].J periodontol 1999,70(10):1125-35
    84. King GN, King N ,Hughes FJ. The effect of root surface demineralization on bone morphogenetic protein-2-induced healing of rat periodontal fenestration defects [J]. J periodontol 1998,69(5):561-70
    85. Danesh-Meyer MJ. Tissue engineering in periodontics and implantology using rhBMP-2[J]. Ann R Australas Coll Dent Surg 2000;15:144-9
    86. Gelse K, von der Mark K, Aigner T, et al. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells [J]. Arthritis Rheum. 2003;48(2):430-41.
    87. Lee JY, Musgrave D, Pelinkovic D, et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells onhealing of critical-sized bone defects in mice [J]. J Bone Joint Surg Am. 2001 Jul;83-A(7):1032-9.
    88. Turgeman G, Pittman DD, Muller R, et al. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy [J]. J Gene Med. 2001;3(3):240-51.
    89. Alden TD, Beres EJ, Laurent JS, et al. The use of bone morphogenetic protein gene therapy in craniofacial bone repair [J] .J Craniofac Surg. 2000:11(1):24-30.
    90. Baltzer AW, Lattermann C, Whalen JD, G et al. Potential role of direct denoviral gene transfer in enhancing fracture repair [J] .Clin Orthop. 2000 Oct;379 (Suppl):S120-5.
    91. Jin QM, Anusaksathien O, Webb SA, et al. Gene therapy of bone morphogenetic protein for periodontal tissue engineering [J] .J Periodontol 2003 Feb;74(2):202-13
    92. Sherman PR, Hutchens LH, Jr, Jewson LG. The effectiveness of subgingival scaling and root planning. Ⅱ. Clinical responses related to residueal calculus [J]. J Periodntol, 1990; 61(1):9-15
    
    
    93. Egelberg J. Regeneration and repair of periodontal tissues[J]. J Periodont Res, 1987;22(3):233
    94. Wolff LF. Guided tissue regeneration in periodontal therapy[J]. Northwest Dent. 2000; 79(6):23
    95. Caffesse RG, Smith BA, Castelli WA, et al. New attachment achieved by guided tissue regeneration in beagle dogs [J]. J Periodontol, 1988; 59(9):589-94
    96. Becker W, Caffesse RG, SMith BA, et al. Class Ⅱ furcations treated by guided tissue regeneration in humans: case reports[J]. J Periodontol, 1990:61 (8):510-4
    97. Teparat T, Solt CW, Claman LJ, et al. Clinical comparison of bioabsorbable barriers with non-resorbable barriers in guided tissue regeneration in the treatment of human intrabony defects [J]. J Periodontol, 1998;69(6):632-41
    98.朱国强,吴织芬.牙周引导组织再生治疗Ⅱ~Ⅲ度根分叉区病变的临床研究.第四军医大学硕士学位论文,2001;18-37
    99.刘宏伟,欧龙,庞劲凡,等。自体骨髓基质细胞用于牙周骨缺损移植的动物实验研究[J].牙体牙髓牙周病学杂志,2000,10(3);117—119
    100. Prato GP, Rotundo R, Magnani C, et al. An autologous cell hyaluronic acid graft technique for gingival augmentation: a case series [J]. J Periodontol. 2003 Feb:74(2):262-7.
    101. Bartold PM, McCulloch CA, Narayanan AS, et al. Tissue engineering: a new paradigm for periodontal regeneration based on molecular and cell biology [J]. Periodontol 2000. 2000 Oct;24:253-69
    102. Van Di jk LJ, Schakenraad JM, van der Voort HM, et al. Cell-seeding of periodontal ligament fibroblasts. A novel technique to create new attachment. A pilot study [J]. J Clin Periodontol. 1991 Mar:18(3):196-9.
    103. HasseI TM. Tissues and cells of the periodontium [J]. Periodontol 2000, 1993:3:9-28
    104. Piche JE, Carnes DL, Graves DT, et al. Initial characterization of cells derived from human periodontaium [J]. J Dent Res, 1989, 68; 5:761-7
    105. Dogan A, Ozdemir A, Kubar A, et al. Assessment of periodontal healing by seeding of fibroblast-like cells derived from regenerated periodontal ligament in artificial furcation defects in a dog:a pilot study [J]. Tissue Eng 2002 Apr;8(2):273-82
    106.欧龙,刘宏伟,庞劲凡.自体牙周膜细胞移植对狗牙周组织再生的影响[J].中华口腔医学杂志,2000;35(1):117—119
    107. Beresford JN. Osteogenic stem cells and the stromal systerm of bone and
    
    bone morrow [J]. Clin Orthop, 1989,240;:270-280
    108.毛天球.骨组织工程的研究[J].中华口腔医学杂志,2001;36(2):158-160
    109. Bhatnagar RS, Qian JJ, Wedrychowska A, et al. Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen [J]. Tissue Eng, 1999;5(1):53
    110.鲁红,吴织芬,田宇,等.人牙周膜细胞体外三维立体培养模型的建立[J],牙体牙髓牙周病学杂志,2002;12(3):132—134
    111.杨维东,毛天球.口腔颌面骨替代材料与骨组织工程[J].实用口腔医学杂志,1999;15:469—471
    112.郭晓东 杜靖远 郑启新 等 分子生物学在组织工程学研究中的应用前景[J].中华实验外科学杂志 2001,18(3):283—284
    113. Giannobile WV, Lee CS, Tomala MP, et al. Platelet-derived growth factor (PDGF) gene delivery for application inperiodontal tissue engineering [J]. J Periodontol. 2001 Jun;72(6):815-23
    114. Guo X, Du J, Zheng Q, et al. Molecular tissue engineering: applications for modulation of mesenchymal stem cells proliferation by transforming growth factor beta 1 gene transfer[J].J Tongji Med Univ. 2001;21(4):314-7.
    115. Krebsbach PH, Renny KG, Franceshi RT, et al. Gene therapy-directed osteogenesis: BMP-7 transduced human fibroblasts form bone in vivo[J]. Hum Gene Ther, 2000, 11:1201-1210.
    116. Lee WC, Zhong C, Qian S, et al. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta [J]. Transplantation. 1998 Dec 27;66(12):1810-7.
    117. Sonntag KC, Emery DW, Yasumoto A, et al. Tolerance to solid organ transplants through transfer of MHC class Ⅱ genes [J]. J Clin Invest. 2001 Jan;107(1):65-71.
    118.顾健人,曹雪涛 主编 基因治疗[M].科学出版社生命科学编辑部 北京2002年1月p2~83
    119. Bonadio J, Smiley E, Patil P, et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration [J].. Nat Med. 1999;5(7):753-9.
    120. Lieberman JR, LE LQ, Wu L, et al. Regional gene therapy with a BMP-2-prodicing murine stromal cell line induces heterotpic bone formation in rodents [J]. J orthopaedic research 1998;16(3):330-339
    121. Fang J, Zhu YY, Smiley E, et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes [J]. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5753-8.
    
    
    122. Salyapongse A, Billiar T, Edington H, et al. Gene therapy and tissue engineering [J]. Clin Plast Surg, 1999; 26:663
    123. Evans C, Robbins P. Genetically Augmented tissue engineering of the musculoskeletal systerm [J]. Clin Orthop. 1999;367:410
    124. Trapnell BC, Gorziglia M. Gene therapy using adenoviral vectors [J].Curr Opin Biotechnol. 1994 Dec;5(6):617-25.
    125. Gorziglia MI, Kadan MJ, Yei S, et al. Elimination of both E1 and E2 from adenovirus vectors further improvesprospects for in vivo human gene therapy [J] ..J Virol. 1996 Jun:70(6):4173-8.
    126. Marshall E. Gene therapy death prompts review of adenovirus vector [J]. Science. 1999 Dec 17:286 (5448):2244-5.
    127.司晓辉,杨连甲,金岩.人骨形成蛋白2噬菌粒表达载体的构建与鉴定[J].细胞与分子免疫学杂志,1998,14:141
    128.萨姆布鲁克,EF弗里奇,T曼尼阿蒂斯.分子克隆实验指南(第二版)[M].北京:高等教育出版社;1992:239—294
    129.吴乃虎.基因工程原理(第二版)上册[M].北京:科学出版社,1998;p227
    130. Itoh Y, Tamai M, Yokogawa K, et al. Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells [J]. Anticancer Res. 2002 May-Jun;22(3):1649-53
    131. Ogata N, Nishizawa M, Ando A, et al. Transfection of basic fibroblast growth factor (bFGF) gene or bFGF antisense gene into human retinal pigment epithelial ceils [J]. Graefes Arch Clin Exp Ophthalmol. 1999 Aug;237(8):678-84.
    132.董肇杨,陈玉林,戴方平,等.转染hEGF基因的表皮细胞G418长期筛选后的表达[J].第二军医大学学报,1998;19(增刊):82—84.
    133. Kashanchi F, Araujo J, Doniger J, et al. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53 [J]. Oncogene. 1997 Jan 23;14(3):359-67.
    134.张从纪,李慧增,杨军,等.大鼠颌下腺血管内皮生长因子cDNA的转移及表达 第三军医大学学报 2000:22(2):166—169
    135. Rutherford RB, Moalli M, Franceschi RT, er al. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo [J]. Tissue Eng 2002 Jul;8(3):441-52
    136.成党校,黄桂君,钱桂生.新型基因转染阳离子脂质体研究进展[J].国外医学药学分册 2000,27(5):257—260
    137. Aspenberg P, Turek T. BMP-2 for intramuscular bone indution: effect in squirrel monkeys is dependent on implantation site [J]. Acta Orthop Scandinavica. 1996;67(1):3-8
    
    
    138. Rudkin GH, Yamaguchi DT, Ishida K, et al. Transforming growth factor-beta, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cells [J].J Cell Physiol 1996 Aug;168(2):433-41
    139. Boyan BD, Schwartz Z, Swain LD, et al. Initial effects of partially purified bone morphogenetic protein on the expression of glycosaminoglycan, collagen, and alkaline phosphatase in nonunion cell cultures [J]. Clin Orthop. 1992 May:(278):286-304.
    140. Takuwa Y, Ohse C, Wang EA, et al. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1 [J]. Biochem Biophys Res Commun 1991 Jan 15;174(1):96-101
    141. Yuasa T, Kataoka H, Kinto N, et al. Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2 [J]. J Cell Physiol 2002 Nov:193(2): 225-32
    142. Maeda T, Matsunuma A, Kawane T, et al. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells [J]. Biochem Biophys Res Commun 2001 Jan 26:280(3):874-7
    143.王瓞、林其准.阳离子脂质体介导基因转染的最优化条件[J].生命的化学 1997,17(1)32—34
    144. Magin-Lachmann C, Kotzamanis G, D'Aiuto L, et al. Retrofitting BAts with G418 resistance, luciferase, and oriP and EBNA-1 - new vectors for in vitro and in vivo delivery [J]. BMC Biotechnol. 2003 Feb;3(1):2
    145. Corsi K, Chellat F, Yahia L, et al. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles [J]. Biomaterials. 2003 Mar; 24(7); 1255-64.
    146. Nowling T, Desler M, Kuszynski C, et al. Transfection of embryonal carcinoma cells at high efficiency using liposome-mediated transfection [J]. Mol Reprod Dev. 2002 Nov;63(3):309-17.
    147. San Miguel SM, Goseki-Sone M, Sugiyama E, et al. The effects of retinoic acid on alkaline phosphatase activity and tissue-non-specific alkaline phosphatase gene expression in human periodontal ligament cells and gingival fibroblasts [J].J Periodontal Res. 1998 Oct:33(7):428-33.
    148. Bouvier M, Couble ML, Hartmann DJ, et al. Isolation and characterization of rat alveolar bone cells [J].Cell Mol Biol. 1991;37(5):509-17.
    149. Nojima N, Kobayashi M, Shionome M, et al. Fibroblastic cells derived from bovine periodontal ligaments have the phenotypes of osteoblasts [J]. J Periodontal Res. 1990 May;25(3):179-85.
    
    
    150.李纾,汪说之,樊明文等。人牙龈和牙周韧带成纤维细胞体外矿化能力的比较研究[J].临床口腔医学杂志 2002.10.20;18(5):340-342
    151. Carnes DL, Maeder CL, Graves DT. Cells with osteoblastic phenotypes can be explanted from human gingiva and periodontal ligament [J].. J Periodontol. 1997 Jul;68(7):701-7.
    152. Hillmann G, Steinkamp-Zucht A, Geurtsen W, et al. Culture of primary human gingival fibroblasts on biodegradable membranes. Biomaterials [J]. 2002 Mar;23(6):1461-9.
    153. Lee DA, Reisler T, Bader DL. Expansion of chondrocytes for tissue engineering in alginate beads enhances chondrocytic phenotype compared to conventional monolayer techniques [J]. Acta Orthop Scand. 2003 Feb;74(1):6-15.
    154. Shang Q, Wang Z, Liu W, et al.. Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells. J Craniofac Surg [J]. 2001 Nov;12(6):586-95.
    155. Alsberg E, Anderson KW, Albeiruti A, et al. Cell-interactive alginate hydrogels for bone tissue engineering [J].J Dent Res. 2001 Nov;80(11):2025-9.
    156. Mosahebi A, Simon M, Wiberg M, et al. A novel use of alginate hydrogel as Schwann cell matrix [J]. Tissue Eng. 2001 Oct;7(5):525-34
    157. Shimizu T, Yamato M, Kikuchi A, et al. Cell sheet engineering for myocardial tissue reconstruction [J]. Biomaterials 2003 Jun;24(13):2309-16.
    158. Draget KI, Smidsrod O Skjak-Braek G. et al. Alginate based new materials [J]. Int J Biol Macromol, 1997,21(1-2):47-55
    159. Smidsrod O Skjak-Braek G. Alginate as immobilelization matrix for cells [J]. Trebds Biotechn. 1, 1990,8(3):71-78
    160. Perka C, Spitzer RS, Lindenhayn K, et al. Matrix-mix culture:new methodology for chondrocyte culture and prearation of cartilage transplants [J]. J Biomed Mater res, 2000, 49(3): 305-11
    161. Gutowska A, Jeong B, Jasionowski M. Injectable gels for tissue engineering [J]. Anat Rec. 2001 Aug 1;263(4):342-9.
    162. Paige KT, Cima LG, Yaremchuk MJ, et al. Injectable cartilage [J]. Plast reconstr Surg, 1995, 96(6):1390-8
    163.羊书勇,杨维东,雷德林等。可注射性组织工程骨的初步研究[J]。实用口腔医学杂志,2001,17(4):27—30
    164. Koyano T, Minoura N, Nagura M, et al. Attachment and growth of cultured fibroblast cells on PVA/chitosan-blended hydrogels [J]. J Biomed Mater
    
    Res 1998 Mar 5;39(3): 486-90
    165. Franceschi RT, Wang D, Krebsbach PH, et al. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7 [J]. J Cell Biochem 2000 Jun 6; 78(3):476-86
    166. Kuo CK, Ma PX. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties [J]. Biomaterials. 2001 Mar;22(6):511-21
    167. Marttinen A, lehto M. Cell culture microassay measuring new formation induced by native bone morphgenetic protein. In liddholm TS: Skeletal reconstruction and Bioimplantation, p17~21,1997:texas,Landes Bioscience Company.
    168. Komori, YagiS, Nomura S, et al. Taarget distrruption of Cbfal results in acomplete lack of bone formation owing to maturational arrest of osteoblasts [J]. Cell,1997;89(5):755-64
    169. Shapiro L, Cohen S. Novel alginate sponges for cell culture and transplantation [J]. Biomaterials. 1997;18(8):583-590
    170.陈书军,雷德林,杨维东.以藻酸钙为载体的软骨组织工程研究 第四军医大学硕士研究生论文 西安 2000年7月p-37